Canada Markets open in 4 hrs 16 mins

Allakos Inc. (ALLK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.52-0.01 (-0.15%)
At close: 04:00PM EST
6.52 0.00 (0.00%)
Pre-Market: 04:37AM EST

Allakos Inc.

975 Island Drive
Suite 201
Redwood City, CA 94065
United States
650 597 5002
https://www.allakos.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees167

Key Executives

NameTitlePayExercisedYear Born
Dr. Robert Alexander Ph.D.CEO & Director1.45M1.16M1970
Dr. Adam L. Tomasi Ph.D.Pres & COO1.09M750.05k1970
Mr. Mark AsburyChief Legal Officer & Gen. Counsel719.87kN/A1963
Dr. Henrik Sandvad RasmussenStrategic Advisor880.07kN/A1959
Mr. Baird Radford IIIChief Financial OfficerN/AN/AN/A
Dr. Ruby Casareno Ph.D.Sr. VP of Technical OperationsN/AN/AN/A
Dr. Sally D. BolmerSr. VP of Regulatory Affairs & Drug Devel.N/AN/AN/A
Mr. Tim VaracekChief Commercial OfficerN/AN/AN/A
Dr. Craig Paterson M.D.Chief Medical OfficerN/AN/AN/A
Mr. Alan ChangDirector of Medical Affairs & Data AnalyticsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Allakos Inc. operates as a clinical stage biopharmaceutical company. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic esophagitis. The is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria, and indolent systemic mastocytosis. Allakos Inc. was incorporated in 2012 and is headquartered in Redwood City, California.

Corporate Governance

Allakos Inc.’s ISS Governance QualityScore as of September 26, 2021 is 10. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.